Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Gene Flow02:39

Gene Flow

Gene flow is the transfer of genes among populations, resulting from either the dispersal of gametes or from the migration of individuals.
Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters01:16

Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters

The pharmacogenetics of drug transporters is increasingly recognized as a critical factor influencing interindividual variability in drug absorption, distribution, and elimination. These membrane-bound proteins regulate drugs' movement across cellular barriers by actively pumping them out (efflux) or facilitating their uptake (influx). Among the major transporter families, ATP-binding cassette (ABC) and solute carrier (SLC) transporters play particularly prominent roles. Genetic polymorphisms...
Gene Evolution - Fast or Slow?02:05

Gene Evolution - Fast or Slow?

The genomes of eukaryotes are punctuated by long stretches of sequence which do not code for proteins or RNAs. Although some of these regions do contain crucial regulatory sequences, the vast majority of this DNA serves no known function. Typically, these regions of the genome are the ones in which the fastest change, in evolutionary terms, is observed, because there is typically little to no selection pressure acting on these regions to preserve their sequences.
In contrast, regions which code...
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
Principles of Pharmacogenetics: Types of Genetic Variants01:27

Principles of Pharmacogenetics: Types of Genetic Variants

The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Insights into demographic and cultural influences on the oral microbiome from historical Japanese dental calculus.

Scientific reports·2026
Same author

Collagen of ancient bones gives an indication of endogenous DNA preservation based on next-generation sequencing technology.

Anthropological science : journal of the Anthropological Society of Nippon = Jinruigaku zasshi·2026
Same author

Demographic history of the Jomon people: insights from whole-mitogenome analysis.

Anthropological science : journal of the Anthropological Society of Nippon = Jinruigaku zasshi·2026
Same author

Serum soluble PD-L1 predicts hepatocellular carcinoma development across distinct virological cohorts of chronic hepatitis C.

Hepatology international·2026
Same author

Ancient genomes reveal early-stage admixture and genetic diversity in the Northwestern Kyushu Yayoi.

Scientific reports·2026
Same author

Simultaneous assessment of one-hour plasma glucose levels and age as a potential predictor of glucose intolerance development in individuals with normal glucose tolerance.

Diabetes research and clinical practice·2026

Related Experiment Video

Updated: Jul 11, 2026

Improved Polymerase Chain Reaction-restriction Fragment Length Polymorphism Genotyping of Toxic Pufferfish by Liquid Chromatography/Mass Spectrometry
09:34

Improved Polymerase Chain Reaction-restriction Fragment Length Polymorphism Genotyping of Toxic Pufferfish by Liquid Chromatography/Mass Spectrometry

Published on: September 20, 2016

FTO polymorphisms in oceanic populations.

Jun Ohashi1, Izumi Naka2, Ryosuke Kimura3

  • 1Department of Human Genetics, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-0033, Japan. juno-tky@umin.ac.jp.

Journal of Human Genetics
|October 12, 2007
PubMed
Summary
This summary is machine-generated.

The "thrifty genotype" hypothesis may not explain obesity in Oceanic populations. Common fat mass and obesity (FTO) gene variants showed no association with body mass index (BMI) in this study.

More Related Videos

A Method to Study the C924T Polymorphism of the Thromboxane A2 Receptor Gene
07:00

A Method to Study the C924T Polymorphism of the Thromboxane A2 Receptor Gene

Published on: April 1, 2019

In Vivo Modeling of the Morbid Human Genome using Danio rerio
12:31

In Vivo Modeling of the Morbid Human Genome using Danio rerio

Published on: August 24, 2013

Related Experiment Videos

Last Updated: Jul 11, 2026

Improved Polymerase Chain Reaction-restriction Fragment Length Polymorphism Genotyping of Toxic Pufferfish by Liquid Chromatography/Mass Spectrometry
09:34

Improved Polymerase Chain Reaction-restriction Fragment Length Polymorphism Genotyping of Toxic Pufferfish by Liquid Chromatography/Mass Spectrometry

Published on: September 20, 2016

A Method to Study the C924T Polymorphism of the Thromboxane A2 Receptor Gene
07:00

A Method to Study the C924T Polymorphism of the Thromboxane A2 Receptor Gene

Published on: April 1, 2019

In Vivo Modeling of the Morbid Human Genome using Danio rerio
12:31

In Vivo Modeling of the Morbid Human Genome using Danio rerio

Published on: August 24, 2013

Area of Science:

  • Genetics
  • Anthropology
  • Obesity Research

Background:

  • The "thrifty genotype" hypothesis proposes that certain gene variants promote obesity, particularly in populations experiencing rapid environmental change.
  • Common variants in the fat mass and obesity (FTO) gene are linked to body mass index (BMI) and obesity in European populations.

Purpose of the Study:

  • To investigate the population frequencies of specific FTO gene variants (rs1421085-C, rs17817449-G, rs9939609-A) in six Oceanic populations.
  • To test for an association between these FTO polymorphisms and BMI in Melanesians, Micronesians, and Polynesians.

Main Methods:

  • Genotyping of common FTO variants (rs1421085-C, rs17817449-G, rs9939609-A) in individuals from six Oceanic populations.
  • Statistical analysis to determine the association between FTO variant frequencies and Body Mass Index (BMI).
  • Assessment of linkage disequilibrium among the studied FTO variants.

Main Results:

  • The investigated FTO polymorphisms were found in 4.2–30.3% of the Oceanic populations studied.
  • No significant association was observed between the FTO polymorphisms and BMI in the Oceanic populations, contrasting with findings in European populations.
  • The studied FTO variants were in strong linkage disequilibrium and showed frequencies similar to those in Southeast and East Asian populations.

Conclusions:

  • The study found no evidence to support the "thrifty genotype" hypothesis as an explanation for high body weights in Oceanic populations based on the investigated FTO gene variants.
  • The genetic architecture of obesity in Oceanic populations may differ from that in European populations, suggesting alternative genetic or environmental factors.
  • Frequencies of these FTO variants in Oceanic populations resemble those in Asian populations, indicating potential shared genetic history or migration patterns.